Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy.
about
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrelsThe golden retriever model of Duchenne muscular dystrophy.Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsDuchenne muscular dystrophy gene therapy in the canine model.Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular AtrophyDevelopmental Biology and Regenerative Medicine: Addressing the Vexing Problem of Persistent Muscle Atrophy in the Chronically Torn Human Rotator CuffProspect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease.Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.Circulating Biomarkers for Duchenne Muscular Dystrophy.Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disordersImproving lipoprotein profiles by liver-directed gene transfer of low density lipoprotein receptor gene in hypercholesterolaemia mice.Silencing Nfix rescues muscular dystrophy by delaying muscle regeneration.A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolguExpression profiling of disease progression in canine model of Duchenne muscular dystrophy.Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration.
P2860
Q27321253-51C04D5B-1C5D-4433-AC85-240B05CE5308Q27339979-2C0CAB54-9156-4E75-B86F-389F1B12BE62Q33709114-0C56C504-BF35-4DBE-8214-AB14AE97F3B5Q34152280-A69D37B1-DA1E-4328-9491-8CCB3DB5F9F2Q35641673-7C16FF00-096B-472C-9570-B037AC7A5D76Q36199822-6ED203A8-6E23-4A08-9817-2E48683BB214Q36875163-5B529D8A-267F-4A86-A88A-124C0503F78CQ37021623-9729DA15-9686-4F23-AD1A-9A607F892F97Q37369066-CFC930A6-57B3-480C-B9B1-9C0D54D87BFBQ37548291-664CF3CA-8060-4D8E-915B-EA0294C96476Q37610530-46A45A70-648E-4D5F-BE49-2C07691CFFA5Q38155361-3141FE0E-1A91-4AB9-8FFB-9D11F904E94AQ40678976-F229FFD5-91A2-48D4-A6CD-BF0EC33EBD0EQ42652757-AFBA700B-D535-4DC4-B750-E39F6D28DC96Q47127942-D7512A01-9C39-4A91-AC6B-32321D3C9D47Q52648781-85F630C6-58F8-4855-BB36-30B0C86E3107Q52658995-2CF1B069-29E8-4828-8259-0D3B66D5EFC9
P2860
Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Long-term systemic myostatin i ...... retriever muscular dystrophy.
@ast
Long-term systemic myostatin i ...... retriever muscular dystrophy.
@en
type
label
Long-term systemic myostatin i ...... retriever muscular dystrophy.
@ast
Long-term systemic myostatin i ...... retriever muscular dystrophy.
@en
prefLabel
Long-term systemic myostatin i ...... retriever muscular dystrophy.
@ast
Long-term systemic myostatin i ...... retriever muscular dystrophy.
@en
P2093
P2860
P356
P1433
P1476
Long-term systemic myostatin i ...... retriever muscular dystrophy.
@en
P2093
Caryn Reynolds
Dennis Trafny
Glenn A Walter
Gretchen E Singletary
H Lee Sweeney
Janet Bogan
Jennifer Pham
Joe N Kornegay
Kevin J Morine
Krista Vandenborne
P2860
P304
P356
10.1089/HUM.2011.102
P577
2011-08-30T00:00:00Z